Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × veliparib × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Gliosarcoma 1 Glioblastoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Rituximab 25 Cyclophosphamide 23 Lenalidomide 20 Prednisone 11 fludarabine 10 Vincristine 10 Doxorubicin 10 obinutuzumab 8 Bendamustine Hydrochloride 8 zanubrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 tazemetostat 6 fludarabine phosphate 6 Biopsy 6 R-CHOP protocol 4 ibrutinib 3 Therapeutics 3 Radiotherapy 3 Exercise 3 Cyclosporine 3 venetoclax 2 tislelizumab 2 tisagenlecleucel 2 pirtobrutinib 2 copanlisib 2 axicabtagene ciloleucel 2 Whole-Body Irradiation 2 Temozolomide 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡